早孕期联合筛查后非典型染色体异常的检出率与产后诊断残余风险
结果显示,若仅对高风险者行NIPT而不做侵入性检测,活产儿非典型染色体异常的残余风险约为0.05%(1:2000)。若所有风险≥1:200且NIPT覆盖至1:1000,常见三体/性染色体异常检出率95%,非典型异常55%。结论提示对cFTS高风险者普遍提供NIPT可能使非典型染色体异常活产儿增加三倍。
要点
- cFTS后高风险孕妇若仅做NIPT,活产儿非典型染色体异常残余风险约0.05%(1:2000)。
- 风险≥1:200行侵入性检测且NIPT覆盖至1:1000,常见三体/性染色体异常检出95%,非典型异常55%。
- 对cFTS高风险者普遍提供NIPT可能使非典型染色体异常活产儿增加三倍。
核心结论
- 对cFTS高风险孕妇普遍提供NIPT而非侵入性检测,将导致非典型染色体异常活产儿数量增加三倍。
主要发现
- 队列中临床显著染色体异常852例(0.7%),其中非典型染色体异常占12%。
- 40%的非典型异常因流产/宫内胎儿死亡或超声畸形而被检出。
- 未行侵入性检测时,活产儿非典型染色体异常的背景风险为0.05%(1:2000)。
- 风险≥1:200行侵入性检测且NIPT覆盖至1:1000时,常见三体/性染色体异常检出率95%,非典型异常55%。
关键数值与推荐
- 高风险定义:cFTS风险≥1:200。
- NIPT覆盖风险阈值:1:1000。
- 活产儿非典型染色体异常残余风险:0.05%(1:2000)。
临床怎么用
- cFTS高风险孕妇选择NIPT而非侵入性检测时,需告知非典型染色体异常的残余风险及可能漏诊。
- 咨询时应说明NIPT策略下非典型染色体异常检出率有限,可能增加产后诊断。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To determine the detection rates of all types of chromosome aberrations and the residual risk for postnatal diagnosis of an atypical chromosome aberration depending on the strategy for further investigation with either noninvasive prenatal testing (NIPT) or invasive testing in pregnancies with increased risk following combined first-trimester screening (cFTS). METHODS: A review of all pregnancies examined with cFTS during 2010 to 2017. RESULTS: The cohort consisted of 129 493 pregnancies. There were 852 (0.7%) clinically significant chromosome aberrations, including aberrations detected later on or after birth. A total of 12% were atypical chromosome aberrations. Considering that 40% were detected due to a miscarriage/intrauterine fetal death or a malformation on ultrasound there is a 0.05% (1:2000) background risk of a postnatal diagnosis of a liveborn child with an atypical chromosome aberration if no further invasive test is performed during pregnancy. If all women with an increased risk (≥1:200) had an invasive test and NIPT was performed up to a risk of 1:1000, 95% of common trisomies/sex chromosome aberrations and 55% of atypical aberrations would be detected. CONCLUSIONS: If NIPT was offered to all women with an increased risk following cFTS it would imply that three times as many children would be born with an atypical chromosome aberration.
引用
- Iwarsson E, Conner P. Detection rates and residual risk for a postnatal diagnosis of an atypical chromosome aberration following combined first-trimester screening. Prenat Diagn. 2020. PMID: 32274819. doi:10.1002/pd.5698
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。